Roche is relying on hemophilia newcomer Hemlibra to crank out major sales, and the company got two pieces of good news on that front early this week.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,